Zobrazeno 1 - 6
of 6
pro vyhledávání: '"K T, Lappegård"'
Publikováno v:
Journal of Internal Medicine. 257:558-560
During the course of an inflammatory process in the thoracic part of the spinal cord, a previously healthy male suffered two myocardial infarctions in separate coronary territories. A coronary angiogram revealed only minor wall changes in one coronar
Publikováno v:
Scandinavian journal of immunology. 76(3)
Low-density lipoprotein (LDL) apheresis is an extracorporeal treatment modality used in high-risk patients when LDL cholesterol levels cannot be reduced adequately with medication. The treatment is highly effective, but could be affected by potential
Autor:
K T, Lappegård, H, Aass
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 120(20)
Fabry's disease is an X-linked inborn error of metabolism. The patients lack or have very low activity of the enzyme alpha-galactosidase A. This results in deposition of sphingolipids in endothelial cells and vascular smooth muscle cells; thus the di
Autor:
K T, Lappegård
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 120(27)
Warfarin is the major oral anticoagulant drug used in Norway. The effect is monitored by measuring the patient's prothrombin time expressed as international normalized ratio (INR). The dose necessary to achieve a therapeutic INR varies. A few patient
Publikováno v:
Thrombosis research. 99(1)
A novel enzyme immunoassay for plasma thrombospondin (TSP) based on commercially available monoclonal antibodies was established. The following conditions for correct collection and preservation of blood samples were required: venipuncture directly i
Autor:
K T, Lappegård
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 109(25)
Chronic granulomatous disease is an inherited disorder characterized by recurrent infections from early childhood. The disease is due to reduced production of reactive oxygen intermediates in host phagocytes, causing inefficient killing of bacteria.